Purpose of this clinical phase 1 trial was to determine if
para-chloro-2-[18F]fluoroethyletomidate positron emission computed tomography
([18F]CETO-positron emission computed tomography(PET)/computed tomography(CT)) can be used in
diagnostics of adrenal tumors and if the biochemical/pharmacological states conditions in
humans with various illnesses, compared to healthy humans, such as the radio tracer is
suitable?
Phase:
Early Phase 1
Details
Lead Sponsor:
Uppsala University
Collaborators:
British Medical Research Council Uppsala University Hospital